Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects Read More > January 20, 2017
Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies Read More > January 19, 2017
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens Read More > January 18, 2017
Harmine, a Novel DNA Methyltransferase 1 Inhibitor in the Leukemia Cell Line Read More > January 17, 2017
Hyperthermia Severely Affects the Vascular Effects of MDMA and Metabolites in the Human Internal Mammary Artery In Vitro Read More > January 13, 2017
Weak phantasy and visionary phantasy: the phenomenological significance of altered states of consciousness Read More > January 3, 2017
Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature Read More > January 1, 2017
Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness? Read More > January 1, 2017
